EC Microbiology

Research Protocol Volume 18 Issue 8 - 2022

Anti-Viral Activity of Thymol against Influenza A Virus

Tanusri Nandi and Madhu Khanna*

Department of Microbiology (Virology), Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India

*Corresponding Author: Madhu Khanna, Professor, Department of Microbiology (Virology), Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
Received: July 20, 2022; Published: July 28, 2022



Thymol is an established anti-parasitic drug against Trypanosoma brucei rhodesiense. Thymol is characterized as small molecule drug mainly isolated from Thymus vulgaris and Trachyspermum ammi. The active compound of thymol, 2-isopropyl-5-methylphenol, is a natural monoterpenoid phenol shows potent anti-microbial action against numerous gram positive and negative bacteria as well as fungal species. The objective of the study was to elucidate the anti-influenza effect of thymol in A549 cells. The data represents the effect of thymol on influenza A virus replication. Assessment of cytotoxicity of thymol was checked by MTT assay and 50% of minimal toxic concentration was found at 49.4 µg/ml. The inhibitory effect of thymol was analyzed by quantitative RT-PCR and western blotting. When treated with thymol at different concentrations only 50 and 25 µg/ml showed inhibition in expression compared to control at 24hr in both RNA and protein level. This is the first study which showed that thymol exhibited significant anti-influenza efficacy in A549 cells.

Keywords: Thymol; Influenza A Virus; Anti-Viral; Quantitative RT-PCR and Western Blot

  1. Nagoor Meeran MF., et al. “Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development”. Frontiers in Pharmacology8 (2017): 380.
  2. Youssefi MR., et al. “Efficacy of Two Monoterpenoids, Carvacrol and Thymol, and Their Combinations against Eggs and Larvae of the West Nile Vector Culex pipiens”. Molecules2410 (2019): 1867.
  3. Lucia A., et al. “Nanoemulsions based on thymol-eugenol mixtures: characterization, stability and larvicidal activity against Aedes aegypti”. Bulletin of Insectology1 (2020): 153-160.
  4. Garcia-Bustos JF., et al. “An appraisal of natural products active against parasitic nematodes of animals”. Parasites and Vectors121 (2019): 306.
  5. Tasdemir D., et al. “Antiprotozoal Activity of Turkish Origanum onites Essential Oil and Its Components”. Molecules24.23 (2019): 4421.
  6. Rúa J., et al. “Combination of Carvacrol and Thymol: Antimicrobial Activity against Staphylococcus aureus and Antioxidant Activity”. Foodborne Pathogens and Disease9 (2019): 622-629.
  7. Marchese A., et al. “Antibacterial and antifungal activities of thymol: a brief review of the literature”. Food Chemistry210 (2016): 402-414.
  8. Kubiça TF., et al. “In vitro inhibition of the bovine viral diarrhoea virus by the essential oil of Ocimum basilicum (basil) and monoterpenes”. The Brazilian Journal of Microbiology451 (2014): 209-214.
  9. Makau JN., et al. “A Quinolinone Compound Inhibiting the Oligomerization of Nucleoprotein of Influenza A Virus Prevents the Selection of Escape Mutants”. Viruses 12 (2020): 337.
  10. Dou D., et al. “Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement”. Frontiers in Immunology 9 (2018): 1581.
  11. Caini S., et al. “The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century”. PLOS ONE9 (2019): e0222381.
  12. Astani A., et al. “Comparative Study on the Antiviral Activity of Selected Monoterpenes Derived from Essential Oils”. Phytotherapy Research5 (2010): 673-679.
  13. Zeghib A., et al. “Antibacterial, Antiviral, Antioxidant and Antiproliferative Activities of Thymus guyonii Essential Oil”. Natural Product Research 16 (2019): 1-4.
  14. Lai WL., et al. “Inhibition of Herpes Simplex Virus Type 1 by Thymol-Related Monoterpenoids”. Planta Medica15 (2012): 1636-1638.

Tanusri Nandi and Madhu Khanna. Anti-Viral Activity of Thymol against Influenza A Virus.EC Microbiology 18.8 (2022): 98-103.